HEALTH● LOWAug 26 · Aug 26, 2026, 1:45 AM
Caliway CBL - 514 Combination Therapy Cleared by U . S . FDA for Phase 2 Trial ; Pivotal Phase 3 Trial SUPREME - 01 Initiates Enrollment
prnewswire.com · United States
Caliway's CBL-514 combination therapy has been cleared by the U.S. FDA for a Phase 2 trial, and its pivotal Phase 3 trial, SUPREME-01, has begun enrollment. This marks significant progress in the development of a new medical treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
See it on the live mapUnited States and nearby eventsMore from United StatesLatest stories and threat level
More from United States
POLITICS5h agoUnited States denies Ada Colau visa to participate in a cities meeting in Puerto RicoEl PaísBUSINESS9h agoWho is Rahul Agarwal ? Indian - origin inventor who secured a ₹3 . 3 crore deal on Shark Tank united states for reimagined spoonslivemint.com · IndiaPOLITICS18h ago“In a word, it’s a disaster”: In the United States, the frightening evolution of the Ministry of Health under Robert F. KennedyLe Figaro InternationalHEALTH1d agoDistinguished clinician - scientist Professor Marcus Ong is first Singaporean emergency medicine physician elected to National Academy of Medicine , united states bruneinews.net · Malaysia
More in Health
HEALTH9m agoEbola: We Have A problem With Delayed Diagnosis, Resources To Cope — Medical DoctorChannels TVHEALTHBREAKING16m agoNigeria records its first Ebola case amid rapid regional spreadFrance 24 [en]HEALTH21m agoRoivant to seek label expansion for Lisraya in uveitis after late-stage trial winSeeking Alpha TechHEALTH23m agoNeurologist on multiple sclerosis warning signs to look out forCBS News